The FDA approves first U.S. at-home tool as a Pap-smear alternative

The Food and Drug administration has approved the U.S.’s first at-home alternative to the Pap smear, a procedure generations of women have dreaded and often found painful.

The new device by Teal Health will offer a “much preferred experience,” the company said in its announcement, and also aims to increase screening rates by making the procedure more convenient.

Traditionally, gynecologists have inserted a cold metal speculum deep into a woman’s vagina to scrape cells from the cervix.

The Teal Wand — “built with empathy,” the company said — uses a swab to collect a vaginal sample. Women will then mail the sample to a lab that will screen for HPV (human papillomavirus), the virus that causes nearly all cervical cancers. A growing body of research has found HPV testing to be highly accurate.

The FDA approval Friday follows a U.S.-based study that found at-home screening was just as effective as that done in a doctor’s office. The study also found women overwhelmingly preferred self–screening at home, and said they’d be more likely to stay up to date with cervical cancer screenings that way.

Every year, about 13,000 cases of cervical cancer are diagnosed, and more than 4,000 women die from the disease. Rates are down dramatically since Dr. Georgios Papanicolaou published a 1943 paper on how to use the Pap smear for screening, and it then became common.

But about a quarter of women in the U.S. are behind on such screenings, and medical experts say reducing that is key to the ultimate goal of eliminating cervical cancer. There’s also a racial gap, with Black and Native American women far more likely to die from cervical cancer than white women. The HPV vaccine for teen and preteen girls, introduced in 2007, has also led to a global push to tackle the disease that way.

At-home cervical cancer screenings are already available in several other countries, including Australia and Sweden.

Teal Health says its self-testing device will be available starting next month, in California first and then expanding. It will be by prescription, through a telehealth service, for women 25-65 years old who are “at average risk.” The company says it’s working with insurance companies to provide coverage.

 

After the CDC shooting, federal workers pressure RFK Jr. for more protections

More than 750 current and former HHS employees signed a letter to Health Secretary Robert F. Kennedy, Jr. demanding he stop spreading inaccurate information and guarantee the safety of the workforce.

Ticks are migrating, but scant surveillance may leave doctors in the dark on patient treatment

Health departments struggle to adequately survey for ticks to warn doctors about new species and the diseases they carry.  

These brain implants speak your mind — even when you don’t want to

Brain-implanted devices that allow paralyzed people to speak can also decode words they imagine, but don't intend to share.

Voting officials are leaving their jobs at the highest rate in decades

Some 2 in 5 of all the local officials who administered the 2020 election left their jobs before the 2024 cycle, new research has found.

Trump’s return to ‘law and order’ highlights a sore spot for Democrats: crime policy

Democrats have struggled to counter GOP efforts to frame itself as the party of "law and order." Some see it as a problem of messaging, while others think past and current policies may be to blame.

Nerd! How the word popularized by Dr. Seuss went from geeky insult to mainstream

Nerd has been part of our lexicon for three-quarters of a century, its geeky meaning embodied by some of the most recognizable characters in film and TV, but its origin story is a bit murky.

More Front Page Coverage